Intraarterial Dexamethasone for Pain Relief After Uterine Fibroid Embolization: A Randomized Clinical Trial. | ClinicLens

Acute postprocedural pain remains a major barrier to uterine fibroid embolization (UFE). To assess whether intraarterial dexamethasone reduces postprocedural pain after UFE. This double-blind, placebo-controlled randomized clinical trial was conducted from July 2020 to December 2

Medical Literature · Updated 2026-08-02

← Back to articles

This standalone article is served from the ClinicLens content archive.

If the embedded page does not load in your browser, open it directly.